Search

There is a scarcity of research on drug use patterns among HIV-positive young individuals in Sub-Saharan Africa (YLWH). To fill the gap, the following was set out:

1. compare the prevalence of substance use, specifically alcohol and illicit...

Stigma among healthcare providers is a barrier to the effective delivery of mental health services in primary care. Few studies have been conducted in primary care settings comparing the attitudes of healthcare providers and experiences of...

Supply reduction is often the main approach used for addressing the illicit drug problem.

Evaluating drug policy is an integral part of a cost-efficient approach to tackle illicit drugs. This report takes a first step towards a systematic...

Evaluation is an integral part of a good governance approach to public policy. This principle applies equally to the component of drug policy designed to counter the availability of and access to illicit drugs. Estimation or full costing of...

Abstract

Greece represent a unique case for investigating harm reduction policy since the unprecedented economic recession and the radical austerity programs coupled with the auxiliary effects of an unstable, punitive political...

Abstract

Dimensional models for classifying personality have received extensive empirical support in the treatment of substance misuse. However, we do not currently understand whether and which dimensions of personality functioning are...

Abstract

Background: Treatment retention is a major factor contributing to favourable outcome in the treatment of substance misuse, but the literature remains very limited. Despite evidence of the association of personality with drug use...

Abstract

Treatment initiation is a major factor contributing to positive outcomes, but the supporting literature remains limited. It is difficult to draw conclusions regarding predictors of dropout, and there is a need to target clients'...

Every two years, the World Health Organization (WHO) publishes its Model List of Essential Medicines (EML), a collection of medicines considered essential by WHO experts.

The purpose of the list is to guide national authorities on the type...

Humberto Nicolini, INMEGEN

María Elena Medina-Mora, Facultad de Psicología, UNAM

Jorge Ameth Villatoro Velázquez, Instituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz"

Marycarmen Noemí Bustos Gamiño, Instituto Nacional de...

SAVANES/LUTTE CONTRE LA DROGUE :LE COMITÉ NATIONAL ANTI-DROGUE PREND SON BÂTON DE PÈLERIN

Le comité national anti-drogue est dans les savanes depuis le 09 novembre dernier, dans le cadre de la campagne de sensibilisation des élus locaux...

Objective: This is the first EMCDDA webinar in the cannabis webinar series, which opens the debate with an all-encompassing overview of the key issues and response options available.

Background: Cannabis is the most widely used illicit...

The second webinar in EMCDDA's cannabis webinar series focuses on the debate around cannabis control approaches across Europe. It will aim to clarify concepts such as depenalisation, decriminalisation and legalisation. Background: Cannabis...

This briefing synthesises existing evidence on alcohol energy (calorie) labelling, spanning the past five years (2016-2021).

This briefing covers reviews in the academic literature about the impact of alcohol energy labelling, studies and...